India to Hungary: Topotecan Export Trade Route

The India to Hungary Topotecan corridor is one of India's established pharmaceutical export routes, with 184 shipments documented worth a combined $98.1K USD. The route is dominated by VENUS REMEDIES LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's topotecan manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $533 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with topotecan's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 29.1%, placing it at rank #3 among India's top topotecan export destinations globally.

On the import side, key buyers of Indian topotecan in Hungary include E P H K, EUROFINS ANALYTICAL SERVICES HUNGAR, TO THE ORDER and 7 others. E P H K is the single largest importer with 3 shipments valued at $59.2K USD.

India's topotecan exports to Hungary are driven primarily by a handful of large-scale manufacturers. VENUS REMEDIES LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Hungary benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VENUS REMEDIES LIMITED, INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $533 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as topotecan for injection 4.0 mg topotecanalpha-medical 4mg batch no. x4kto012a mfg. dt. 11/2024, exp. dt. 10/2026 and topotecan hydrochloride for injection 4.0 mg topotecan alpha-medical 4mg bn.x5bto012a, md.02/2025, ed.01/2027, suggesting that buyers in Hungary tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, E P H K is the largest importer with 3 shipments worth $59.2K USD — representing 60% of all topotecan imports from India on this route. A total of 10 buyers are active on this corridor.